Código QR

Identification of racial disparities across MammaPrint and BluePrint subtypes in HR + HER2- breast cancer

Abstract We compared clinicopathologic features, MammaPrint and BluePrint molecular subtype, and outcomes by race among females with hormone receptor-positive (HR+), HER2- early-stage breast cancer (EBC). Of 1018 participants with HR+ HER2- EBC enrolled from two registries (BEST and FLEX), 509 White...

Descrición completa

Gardado en:
Detalles Bibliográficos
Principais autores: Sonya Reid, Lindsay Venton, Jennifer G. Whisenant, Anne E. Weidner, Jennifer Wei, Harshini Ramaswamy, Christa Dreezen, Nicole Chmielewski-Stivers, Andrea R. Menicucci, William Audeh, Tuya Pal
Formato: Artigo
Idioma:Inglês
Publicado: Nature Portfolio 2026-03-01
Series:npj Breast Cancer
Acceso en liña:https://doi.org/10.1038/s41523-026-00932-1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!